Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Brasília; s.n; 15 jul.2020. 29 p.
No convencional en Portugués | LILACS, BRISA, PIE | ID: biblio-1117674

RESUMEN

O Informe Diário de Evidências é uma produção do Ministério da Saúde que tem como objetivo acompanhar diariamente as publicações científicas sobre tratamento farmacológico e vacinas para a COVID-19. Dessa forma, são realizadas buscas estruturadas em bases de dados biomédicas, referentes ao dia anterior desse informe. Não são incluídos estudos pré-clínicos (in vitro, in vivo, in silico). A frequência dos estudos é demonstrada de acordo com a sua classificação metodológica (revisões sistemáticas, ensaios clínicos randomizados, coortes, entre outros). Para cada estudo é apresentado um resumo com avaliação da qualidade metodológica. Essa avaliação tem por finalidade identificar o grau de certeza/confiança ou o risco de viés de cada estudo. Para tal, são utilizadas ferramentas já validadas e consagradas na literatura científica, na área de saúde baseada em evidências. Cabe ressaltar que o documento tem caráter informativo e não representa uma recomendação oficial do Ministério da Saúde sobre a temática. Foram encontrados 14 artigos e 6 protocolos.


Asunto(s)
Humanos , Neumonía Viral/tratamiento farmacológico , Infecciones por Coronavirus/tratamiento farmacológico , Betacoronavirus/efectos de los fármacos , Sistema Renina-Angiotensina , Evaluación de la Tecnología Biomédica , Omeprazol/uso terapéutico , Dexametasona/uso terapéutico , Oxigenación por Membrana Extracorpórea/instrumentación , Efecto de Cohortes , Enoxaparina/uso terapéutico , Peptidil-Dipeptidasa A/uso terapéutico , Ritonavir/uso terapéutico , Proteína Antagonista del Receptor de Interleucina 1/uso terapéutico , Lopinavir/uso terapéutico , Fibrinolíticos/uso terapéutico , Esomeprazol/uso terapéutico , Darunavir/uso terapéutico , Rituximab/uso terapéutico , Pantoprazol/uso terapéutico , Hidroxicloroquina/uso terapéutico , Anticoagulantes/uso terapéutico
3.
Chinese Acupuncture & Moxibustion ; (12): 239-242, 2018.
Artículo en Chino | WPRIM | ID: wpr-690820

RESUMEN

<p><b>OBJECTIVE</b>On the basic treatment, to observed the effect difference between acupuncture at Zhiyang (GV 9) points combined with pantoprazole and simple pantoprazole for gastroesophageal reflux cough with damp-heat type.</p><p><b>METHODS</b>A total of 102 patients were randomly assigned into an observation group and a control group, 51 cases in each group. The patients in the two groups were given domperidone tablets (10 mg each time, 3 times a day). The patients in the control group were treated with pantoprazole capsule (40 mg each time, once a day). On the basis of the control group, the patients in the observation group were treated with Zhiyang (GV 9) points, once a day, 5 times a week. All the treatment was given for 8 weeks. The indexes were observed before and after treatment, including cough symptom at daytime and nighttime scores, TCM symptom (heartburn, acid regurgitation, chest pain, epigastric pain, throat discomfort) scores and quality of life scores of cough questionnaire in Leicester (physiological, psychological and social aspects). The clinical effects were compared.</p><p><b>RESULTS</b>After treatment, the daytime and nighttime cough scores, TCM symptom (heartburn, acid regurgitation, chest pain, epigastric pain, throat discomfort) scores were lower, and the quality of life scores of cough questionnaire in Leicester (physiological, psychological and social aspects) were higher than those before treatment in the two groups (all <0.05), with better results in the observation group (all <0.05). The total effective rate of the observation group was 94.1% (48/51), which was better than 80.4% (41/51) of the control group (<0.05).</p><p><b>CONCLUSION</b>On the basic treatment, acupuncture at Zhiyang (GV 9) points combined with pantoprazole can improve TCM symptoms, such as cough, of the patients with gastroesophageal reflux cough with damp-heat type, and improve their quality of life.</p>


Asunto(s)
Humanos , 2-Piridinilmetilsulfinilbencimidazoles , Usos Terapéuticos , Puntos de Acupuntura , Terapia por Acupuntura , Terapia Combinada , Tos , Terapéutica , Reflujo Gastroesofágico , Terapéutica , Pantoprazol , Calidad de Vida , Resultado del Tratamiento
5.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery ; (24): 1284-1287, 2015.
Artículo en Chino | WPRIM | ID: wpr-749190

RESUMEN

OBJECTIVE@#To explore the mechanism, clinical characterization, diagnosis and therapeutic approach of vocal process granuloma(VPG) induced by gastroesophageal reflux.@*METHOD@#We performed a retrospective review of 4 cases.@*RESULT@#In 4 male cases, 3 cases had no obvious symptoms of stomach and esophagus and 1 case had symptoms of bloating and acid reflux. Additionally, 4 cases in which lesions were all located to the left side were diagnosed by trial therapy with proton pump inhibitors (PPIs) with good responding. 2 of 4 cases were relapsed after operations. Meanwhile 4 patients were treated by Rabeprazole for acid suppression therapy and 3 cases were cured and 1 invalid case was cured by Pantoprazole. All patients were followed up for 4-48 months with no recurrence.@*CONCLUSION@#Gastroesophageal reflux is an important pathogenic factor to the VPG. The majority of patients with VPG do not have gastroesophageal reflux symptoms. Besides, most lesions located in the left are associated with sleeping position. The diagnosis is mainly based on the laryngoscope examination and trial of acid suppression therapy. Moreover, recurrence risk is high-with simple operation in VPG therefore the main treatment is a antireflux and it is also valid by replacing byother PPI treatment. The treatment must be long enough. Meanwhile, the comprehensive treatment should be noticed.


Asunto(s)
Humanos , Masculino , 2-Piridinilmetilsulfinilbencimidazoles , Usos Terapéuticos , Cartílago Aritenoides , Patología , Reflujo Gastroesofágico , Quimioterapia , Granuloma , Pantoprazol , Inhibidores de la Bomba de Protones , Usos Terapéuticos , Estudios Retrospectivos , Resultado del Tratamiento
6.
Journal of Central South University(Medical Sciences) ; (12): 799-802, 2011.
Artículo en Chino | WPRIM | ID: wpr-814504

RESUMEN

OBJECTIVE@#To observe the clinical efficacy of sequential therapy with pantoprazole in patients with gastro esophageal reflux disease (GERD).@*METHODS@#A total of 80 patients with GERD were double-blindedly randomized into 2 groups: 40 patients received sequential therapy with pantoprazole 40 mg injection, twice daily for 2 weeks, and then pantoprazole 40 mg oral administration,twice daily for 2 weeks; the other 40 patients received pantoprazole 40 mg oral administration alone,twice daily for 4 weeks. Doctors and patients recorded the severity and frequency of heartburn before and during the treatment. The curative effects of the 2 groups were compared.@*RESULTS@#The total effective rate in the sequential therapy group was higher than that of the oral administration group(95.0% vs 77.5%, P<0.05).@*CONCLUSION@#Pantoprazole sequential therapy is effective for GERD.


Asunto(s)
Femenino , Humanos , Masculino , Persona de Mediana Edad , 2-Piridinilmetilsulfinilbencimidazoles , Usos Terapéuticos , Método Doble Ciego , Esquema de Medicación , Reflujo Gastroesofágico , Quimioterapia , Pantoprazol , Inhibidores de la Bomba de Protones , Usos Terapéuticos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA